Enlivex Ltd. (ENLV)
1.11
+0.01
(+0.91%)
USD |
NASDAQ |
Sep 08, 16:00
1.13
+0.02
(+1.80%)
Pre-Market: 08:06
Enlivex Debt to Equity Ratio : 0.0003 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.0003 |
| September 30, 2025 | 0.0401 |
| June 30, 2025 | 0.0252 |
| March 31, 2025 | 0.0244 |
| December 31, 2024 | 0.0226 |
| September 30, 2024 | 0.0288 |
| June 30, 2024 | 0.0292 |
| March 31, 2024 | 0.0346 |
| December 31, 2023 | 0.0343 |
| September 30, 2023 | 0.1165 |
| June 30, 2023 | 0.0985 |
| March 31, 2023 | 0.0925 |
| December 31, 2022 | 0.0853 |
| September 30, 2022 | 0.0831 |
| June 30, 2022 | 0.077 |
| March 31, 2022 | 0.0762 |
| December 31, 2021 | 0.0706 |
| September 30, 2021 | 0.068 |
| June 30, 2021 | 0.0068 |
| March 31, 2021 | 0.0072 |
| December 31, 2020 | 0.0198 |
| September 30, 2020 | 0.0239 |
| June 30, 2020 | 0.0119 |
| March 31, 2020 | 0.0117 |
| December 31, 2019 | 0.0373 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.0281 |
| June 30, 2019 | 0.0267 |
| March 31, 2019 | 0.0213 |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Polyrizon Ltd. | -- |
| NovelStem International Corp. | -0.8748 |
| Brainstorm Cell Therapeutics, Inc. | -0.1185 |
| Summit Therapeutics, Inc. | 0.0324 |
| PeptiDream Inc. | 0.3231 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.327B |
| Total Liabilities (Quarterly) | 392.05M |
| Shareholders Equity (Quarterly) | 1.935B |
| Current Ratio | 193.24 |
| Net Debt Paydown Yield | 0.01% |